Cargando…
A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas)
BACKGROUND: Organ preservation before transplantation is still a challenge. Both the University of Wisconsin and Bretschneider’s histidine-tryptophan-ketoglutarate (HTK; Custodiol®) solution are standard for liver, kidney and pancreas preservation. Organ preservation with both solutions is comparabl...
Autores principales: | Kniepeiss, Daniela, Houben, Philipp, Stiegler, Philipp, Berghold, Andrea, Riedl, Regina, Kahn, Judith, Schemmer, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954515/ https://www.ncbi.nlm.nih.gov/pubmed/31924234 http://dx.doi.org/10.1186/s13063-019-3823-4 |
Ejemplares similares
-
Custodiol-N Is Superior to Custodiol(®) Solution in Experimental Rat Uterus Preservation
por: Zitkute, Viktorija, et al.
Publicado: (2020) -
Custodiol - N versus Custodiol: a prospective randomized double blind multicenter phase III Trial
por: Szabó, Gábor, et al.
Publicado: (2015) -
Custodiol(®) Supplemented with Synthetic Human Relaxin Decreases Ischemia-Reperfusion Injury after Porcine Kidney Transplantation
por: Bausys, Augustinas, et al.
Publicado: (2021) -
Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2015) -
The efficacy of custodiol as blood cardioplegia for myocardial protection in adult cardiac surgery
por: Moursi, Ihab Mohamed Yehya, et al.
Publicado: (2015)